Armistice Capital
DMK

Armistice Capital’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Armistice Capital’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-207,143
Closed -$1.68M – 285
2023
Q1 		$1.68M Buy
+207,143
New +$2.75M 0.02% 129

Other funds holding DMK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cubist Systematic Strategies
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Harbour Investments
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Armistice Capital's DMK Position: Q2 2023 in Review

Armistice Capital sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2023, closing a stake of 207,143 shares — an estimated $1.68M sold.

Armistice Capital first reported a position in DMK in Q1 2023 and held it in 1 quarter. The position peaked at $1.68M in Q1 2023. 22 funds tracked by Wall St. Rank hold DMK as of Q2 2023.

  • Armistice Capital reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2023 after selling out during the quarter.
  • Armistice Capital sold 207,143 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2023, an estimated $1.68M.
  • Armistice Capital first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2023 and held it in 1 quarter.
  • Armistice Capital's DMK Pharmaceuticals Corporation Common Stock position peaked at $1.68M in Q1 2023.
  • 22 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2023.

Based on Armistice Capital's 13F filing for Q2 2023, filed 14 Aug 2023.